The importance of hepatic zinc in the protective effects against obesity and NASH is further supported by our findings that elevated hepatic zinc in Slc39a5-/- mice enhanced hepatic AMPK and hepatic AKT signaling (Figure 5 and Figure 5—figure supplement 1). The gene discussed is SLC39A5; the disease is obesity due to melanocortin 4 receptor deficiency.